Aramore Clinches Coveted Position in BeautyMatter NEXT50 for NAD+ Skincare Innovation
Massachusetts-based skincare trailblazer, Aramore, has earned a prestigious spot on the 2026 BeautyMatter NEXT50 list. This annual honor is bestowed upon the most innovative independent companies that are redefining the future of beauty and wellness. The announcement, made on July 1, 2026, places Aramore among the world’s most disruptive beauty startups.
Aramore’s unique selling point is its groundbreaking application of topical NAD+ science to promote skin longevity. NAD+ (nicotinamide adenine dinucleotide) is a vital molecule for cellular energy production that naturally diminishes with age. Aramore is the pioneer in developing a clinically-proven method to enhance its levels directly in the skin.
The revolutionary technology was conceived by co-founder Dr. Anna Mandinova, a renowned skin biologist from Harvard, in collaboration with a team of MIT scientists. Their exclusive NAD+ Precursor Complex is designed to infiltrate the basal layer of the skin and replenish NAD+ at its origin, thereby rejuvenating the skin’s ability to renew, regenerate, and re-energize at a cellular level.
“Our mission from the outset has been to offer consumers a novel approach to skincare that emphasizes skin performance over mere aesthetics,” stated Melisse Shaban, CEO of Aramore. The BeautyMatter NEXT50 accolade underscores brands that exhibit exceptional growth, unique positioning, and the potential to shape the future of beauty.
Source: PR Newswire — Aramore Selected as a 2026 BeautyMatter NEXT50, July 1, 2026